Japan Angiogenesis Inhibitors Market (2025-2031) | Trends, Segmentation, Growth, Value, Industry, Analysis, Companies, Competitive Landscape, Share, Size & Revenue, Outlook, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 Japan Angiogenesis Inhibitors Market - Industry Life Cycle

3.4 Japan Angiogenesis Inhibitors Market - Porter's Five Forces

3.5 Japan Angiogenesis Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 Japan Angiogenesis Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 Japan Angiogenesis Inhibitors Market Revenues & Volume Share, By Drugs, 2021 & 2031F

3.8 Japan Angiogenesis Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Japan Angiogenesis Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 Japan Angiogenesis Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Japan, driving the demand for angiogenesis inhibitors as a treatment option.

4.2.2 Technological advancements in drug development leading to the introduction of more effective angiogenesis inhibitors in the market.

4.2.3 Favorable regulatory environment supporting the approval and adoption of angiogenesis inhibitors in Japan.

4.3 Market Restraints

4.3.1 High cost associated with angiogenesis inhibitor drugs, limiting affordability and accessibility for some patients.

4.3.2 Stringent regulatory requirements for drug approval and market entry, which can delay the launch of new angiogenesis inhibitors in Japan.

6.1 Japan Angiogenesis Inhibitors Market, By Product

6.1.1 Overview and Analysis

6.1.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 Japan Angiogenesis Inhibitors Market Revenues & Volume, By VEGF Targeted Therapy, 2021- 2031F

6.1.4 Japan Angiogenesis Inhibitors Market Revenues & Volume, By FGF Targeted Therapies, 2021- 2031F

6.1.5 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Oncogene Targeted Therapy, 2021- 2031F

6.1.6 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Matrix Degrading and Remodeling Targeted Therapy, 2021- 2031F

6.1.7 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 Japan Angiogenesis Inhibitors Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Glioblastoma, 2021- 2031F

6.2.3 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.4 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.3 Japan Angiogenesis Inhibitors Market, By Drugs

6.3.1 Overview and Analysis

6.3.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Inlyta, 2021- 2031F

6.3.3 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Avastin, 2021- 2031F

6.3.4 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Revlimid, 2021- 2031F

6.3.5 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 Japan Angiogenesis Inhibitors Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.4.3 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.4.4 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.5 Japan Angiogenesis Inhibitors Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.5.4 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.6 Japan Angiogenesis Inhibitors Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 Japan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

7.1 Japan Angiogenesis Inhibitors Market Export to Major Countries

7.2 Japan Angiogenesis Inhibitors Market Imports from Major Countries

8.1 Patient survival rates post-treatment with angiogenesis inhibitors.

8.2 Number of clinical trials conducted for the development of new angiogenesis inhibitors.

8.3 Adoption rate of angiogenesis inhibitors in different types of cancer treatments in Japan.

9.1 Japan Angiogenesis Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 Japan Angiogenesis Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 Japan Angiogenesis Inhibitors Market Opportunity Assessment, By Drugs, 2021 & 2031F

9.4 Japan Angiogenesis Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Japan Angiogenesis Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 Japan Angiogenesis Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Japan Angiogenesis Inhibitors Market Revenue Share, By Companies, 2024

10.2 Japan Angiogenesis Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters